Quantcast

Latest SLC5A2 Stories

2014-06-16 08:28:40

Novel Once-Daily Formulation of Remogliflozin Etabonate Achieves Ideal Safety and Efficacy Profiles RALEIGH, N.C., June 16, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing new medicines and technologies for the treatment and diagnosis of metabolic disease, presented final results from its two Phase 2b clinical studies evaluating remogliflozin etabonate (a prodrug of remogliflozin, the active inhibitor) at the 74(th) American Diabetes...

2014-06-12 08:29:14

RALEIGH, N.C., June 12, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the treatment and diagnosis of metabolic disease, announced today it will present three peer-reviewed posters relating to its differentiated sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate, at the 74(th) American Diabetes Association (ADA) Scientific Sessions at the Moscone Center in San Francisco, June 13-17. Two of...

2014-01-29 16:29:02

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2qlc2k/lexicons_lx4211) has announced the addition of the "Lexicon's LX4211 - FDA canagliflozin decision is key bellweather" [http://www.researchandmarkets.com/research/2qlc2k/lexicons_lx4211 ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) LX4211 is part of a new class of type 2 diabetes agents that inhibit the SGLT2...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related